ANNEX III, Commission Regulation (EU) No 944/2013 of 2 October 2013 amending, for the purposes of i…

In forcesince 2 Oct 2013

Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling |

Specific Conc. Limits,

M — Factors

Notes

Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s)

031-001-00-4 | gallium arsenide | 215-114-8 | 1303-00-0 | Carc. 1B | H350 | GHS08 | H350 | | |

STOT RE 1 | H372 (respiratory and haematopoietic systems) | Dgr | H372 (respiratory and haematopoietic systems)

050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d |

GHS08

Wng

H361d | | |

050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d |

GHS08

Wng

H361d | | |

050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D |

GHS08

Dgr

H360D | | |

601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D

Asp. Tox. 1 | H304 | GHS07 | H304

STOT SE 3 | H336 |

GHS08

Dgr

H336

606-145-00-1 |

sulcotrione (ISO);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8 | Repr. 2 | H361d | GHS08 | H361d | |

M = 1

M = 10

STOT RE 2 | H373 (kidneys) | GHS07 | H373 (kidneys)

Skin Sens. 1A | H317 | GHS09 | H317

Aquatic Acute 1 | H400 | Wng |

Aquatic Chronic 1 | H410 | | H410

607-699-00-7 |

bifenthrin (ISO);

(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3 | Carc. 2 | H351 | GHS06 | H351 | |

M = 10000

M = 100000

Acute Tox. 3 | H331 | GHS08 | H331

Acute Tox. 2 | H300 | GHS09 | H300

STOT RE 1 | H372 (nervous system) | Dgr | H372 (nervous system)

Skin Sens. 1B | H317 | | H317

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

607-700-00-0 |

indoxacarb (ISO);

methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]

173584-44-6 [1] | Acute Tox. 3 | H301 | GHS06 | H301 | |

M = 1

M = 1

Acute Tox. 4 | H332 | GHS08 | H332

STOT RE 1 | H372 (blood, nervous system, heart) | GHS09 | H372 (blood, nervous system, heart)

Skin Sens. 1B | H317 | Dgr | H317

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;

methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]

144171-61-9 [2] | | | |

607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD |

GHS08

Dgr

H360FD | | |

607-703-00-7 | ammoniumpentadeca- fluorooctanoate | 223-320-4 | 3825-26-1 | Carc. 2 | H351 | GHS08 | H351 | | |

Repr. 1B | H360D | GHS07 | H360D

Lact. | H362 | GHS05 | H362

Acute Tox. 4 | H332 | Dgr | H332

Acute Tox. 4 | H302 | | H302

STOT RE 1 | H372 (liver) | | H372 (liver)

Eye Dam.1 | H318 | | H318

607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. 2 | H351 | GHS08 | H351 | | |

Repr. 1B | H360D | GHS07 | H360D

Lact. | H362 | GHS05 | H362

Acute Tox. 4 | H332 | Dgr | H332

Acute Tox. 4 | H302 | | H302

STOT RE 1 | H372 (liver) | | H372 (liver)

Eye Dam. 1 | H318 | | H318

612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Asp. Tox. 1 | H304 | GHS05 | H304 | |

M = 10

M = 10

STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS08 | H373 (gastro-intestinal tract, liver, immune system)

Skin Irrit. 2 | H315 | GHS09 | H315

Eye Dam. 1 | H318 | Dgr | H318

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Acute Tox. 4 | H302 | GHS05 | H302 | |

M = 10

M = 10

Asp Tox. 1 | H304 | GHS07 | H304

STOT SE 3 | H335 | GHS08 | H335

STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS09 | H373 (gastro-intestinal tract, liver, immune system)

Skin Corr. 1B | H314 | Dgr | H314

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1 | H304 | GHS08 | H304 | |

M = 10

M = 10

STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS05 | H373 (gastro-intestinal tract, liver, immune system)

Skin Irrit. 2 | H315 | GHS09 | H315

Eye Dam. 1 | H318 | Dgr | H318

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4 | H302 | GHS05 | H302 | |

M = 10

M = 10

Asp. Tox. 1 | H304 | GHS07 | H304

STOT SE 3 | H335 | GHS08 | H335

STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS09 | H373 (gastro-intestinal tract, liver, immune system)

Skin Corr. 1B | H314 | Dgr | H314

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4 | H302 | GHS05 | H302 | |

M = 10

M = 10

Asp. Tox. 1 | H304 | GHS07 | H304

STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS08 | H373 (gastro-intestinal tract, liver, immune system)

Skin Corr. 1B | H314 | GHS09 | H314

Aquatic Acute 1 | H400 | Dgr |

Aquatic Chronic 1 | H410 | | H410

616-206-00-4 |

flufenoxuron (ISO);

1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3 | 101463-69-8 | Lact. | H362 | GHS09 | H362 | |

M = 10000

M = 10000

Aquatic Acute 1 | H400 | Wng |

Aquatic Chronic 1 | H410 | | H410

616-207-00-X | polyhexamethylene biguanide hydrochloride | | 27083-27-8 or 32289-58-0 | Carc. 2 | H351 | GHS05 | H351 | |

M = 10

M = 10

Acute Tox. 4 | H302 | GHS07 | H302

STOT RE 1 | H372 (respiratory tract) (inhalation) | GHS08 | H372 (respiratory tract) (inhalation)

Eye Dam. 1 | H318 | GHS09 | H318

Skin Sens. 1B | H317 | Dgr | H317

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

616-208-00-5 |

N-ethyl-2-pyrrolidone;

1-ethylpyrrolidin-2-one

220-250-6 | 2687-91-4 | Repr. 1B | H360D |

GHS08

Dgr

H360D | | |

616-209-00-0 |

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0 | 120923-37-7 | Aquatic Acute 1 | H400 | GHS09 | | |

M = 100

M = 100

Aquatic Chronic 1 | H410 | Wng | H410

616-210-00-6 |

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide

119168-77-3 | Acute Tox. 3 | H301 | GHS06 | H301 | |

M = 10

M = 10

Acute Tox. 4 | H332 | GHS08 | H332

STOT RE 2 | H373 (gastro-intestinal tract) (Oral) | GHS09 | H373 (gastro-intestinal tract) (Oral)

Skin Sens. 1B | H317 | Dgr | H317

Aquatic Acute 1 | H400 | |

Aquatic Chronic 1 | H410 | | H410

616-211-00-1 |

proquinazid (ISO);

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4 | Carc. 2 | H351 | GHS08 | H351 | |

M = 1

M = 10

Aquatic Acute 1 | H400 | GHS09 |

Aquatic Chronic 1 | H410 | Wng | H410